These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 1662889)

  • 1. Temafloxacin: an overview.
    Pankey GA
    Am J Med; 1991 Dec; 91(6A):166S-172S. PubMed ID: 1662889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of uncomplicated urinary tract infections with temafloxacin.
    Iravani A
    Am J Med; 1991 Dec; 91(6A):124S-128S. PubMed ID: 1662882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomefloxacin and temafloxacin: two new fluoroquinolone antimicrobials.
    Symonds WT; Nix DE
    Clin Pharm; 1992 Sep; 11(9):753-66. PubMed ID: 1325892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluoroquinolone antibiotics: properties of the class and individual agents.
    Stratton C
    Clin Ther; 1992; 14(3):348-75; discussion 347. PubMed ID: 1638577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of temafloxacin against gram-negative bacteria: an overview.
    Hardy DJ
    Am J Med; 1991 Dec; 91(6A):19S-23S. PubMed ID: 1662890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of temafloxacin versus ciprofloxacin in lower respiratory tract infections: a randomized, double-blind trial.
    Lindsay G; Scorer HJ; Carnegie CM
    J Antimicrob Chemother; 1992 Jul; 30(1):89-100. PubMed ID: 1331020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of temafloxacin and other fluoroquinolones against typical and atypical community-acquired respiratory tract pathogens.
    Hardy DJ
    Am J Med; 1991 Dec; 91(6A):12S-14S. PubMed ID: 1662881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of temafloxacin against respiratory pathogens.
    Swanson RN; Hardy DJ; Chu DT; Shipkowitz NL; Clement JJ
    Antimicrob Agents Chemother; 1991 Mar; 35(3):423-9. PubMed ID: 2039192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women.
    Stein GE; Philip E
    J Fam Pract; 1992 Feb; 34(2):180-4. PubMed ID: 1310715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temafloxacin compared with ciprofloxacin in mild to moderate lower respiratory tract infections in ambulatory patients. A multicenter, double-blind, randomized study.
    Chodosh S
    Chest; 1991 Dec; 100(6):1497-502. PubMed ID: 1659975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can fluoroquinolones be considered once-daily therapy?
    Neu HC
    J Clin Pharmacol; 1992 Aug; 32(8):692-7. PubMed ID: 1487557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract.
    Langtry HD; Lamb HM
    Drugs; 1998 Sep; 56(3):487-515. PubMed ID: 9777318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
    Ernst ME; Ernst EJ; Klepser ME
    Am J Health Syst Pharm; 1997 Nov; 54(22):2569-84. PubMed ID: 9397218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral temafloxacin compared to norfloxacin for the treatment of complicated urinary tract infections.
    Cox CE
    Am J Med; 1991 Dec; 91(6A):129S-133S. PubMed ID: 1662883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro activity of temafloxacin, against gram-positive bacteria.
    Mandell LA; Lawrence T; Rotstein C; Gorzynski EA; Beam TR; Amsterdam D
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():15-24. PubMed ID: 1664826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin and sparfloxacin: new quinolone antibiotics.
    Martin SJ; Meyer JM; Chuck SK; Jung R; Messick CR; Pendland SL
    Ann Pharmacother; 1998 Mar; 32(3):320-36. PubMed ID: 9533064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of temafloxacin in the community setting: an overview.
    Ball P
    J Antimicrob Chemother; 1991 Dec; 28 Suppl C():121-30. PubMed ID: 1664825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.